RESTENOSIS AFFECTS 20% TO 40% of de novo coronary lesions

treated with bare metal stents. “RESTENOSIS AFFECTS 20% TO 40% of de novo coronary lesions treated with bare metal stents.1 Although it is often considered a benign proces...